Welcome to our dedicated page for Cresco Labs news (Ticker: CRLBF), a resource for investors and traders seeking the latest updates and insights on Cresco Labs stock.
Cresco Labs Inc. reports developments in branded cannabis products, retail dispensaries, cultivation, production and state-regulated market access. The company operates Sunnyside dispensaries and distributes cannabis brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi.
Recurring updates cover quarterly financial results, dispensary openings, medical and adult-use market activity, cannabis licensing matters and operational growth initiatives. Company communications also address branded product distribution, retail execution, balance sheet and cash-flow themes, community outreach, workforce development and legislative or regulatory engagement in the cannabis industry.
Cresco Labs (OTCQX: CRLBF) reported that the Texas Department of Public Safety corrected its conditional license tabulation under the Texas Compassionate Use Program, affecting multiple applicants. The conditional license previously awarded to Cresco Labs Texas, LLC has been rescinded, and the entity is now on the TCUP eligibility list.
Cresco Labs remains confident in its application, is evaluating options to work with the state, and is eligible for a conditional license if any of the 12 current conditional licensees fail due diligence or operational requirements.
Cresco Labs (OTCQX: CRLBF) reported Q1 2026 revenue of $151 million, gross profit of $75 million and Adjusted gross profit of $77 million (Adjusted gross margin 50.7%). SG&A was $54 million (36.0% of revenue); Adjusted SG&A was $51 million (33.7%). Net loss was $17 million; Adjusted EBITDA was $33 million (Adjusted EBITDA margin 21.7%).
As of March 31, 2026, cash and equivalents were $67 million; senior secured term loan was $310 million and mortgage loan $19 million. Subsequent items include conditional Texas medical license award, nine PA dispensary management openings, and two Ohio dispensary openings.
Cresco Labs (OTCQX: CRLBF) opened Sunnyside Aberdeen in Aberdeen, Ohio on May 5, 2026. This is the company’s second Ohio dispensary opened within a month, bringing Cresco Labs to 8 locations in Ohio and 74 locations nationally. Store hours are 9 a.m.–9 p.m.; pickup available at www.sunnyside.shop.
Cresco Labs (OTCQX:CRLBF) will report first quarter 2026 financial results on Friday, May 8, 2026 before the market opens. The company will host an earnings conference call and webcast at 8:30 am ET. Archived webcast access will be available for one year on the investor relations website.
Cresco Labs (OTCQX: CRLBF) opened Sunnyside Bridgeport at 435 Main Street, Bridgeport, Ohio on April 10, 2026. It is Cresco Labs' seventh dispensary in Ohio and its 73rd across the U.S.
The store is open daily 9 a.m.–9 p.m., sells Cresco Labs brands including Cresco, Supply, Good News, Mindy’s and Wonder, and offers online ordering for pickup at www.sunnyside.shop.
Cresco Labs (OTCQX: CRLBF) announced on April 2, 2026 that it was conditionally awarded a Texas Compassionate Use Program license. The vertically integrated license permits Cresco Labs to cultivate, process and dispense medical cannabis in Texas.
The company said the award supports its state-by-state growth strategy, enables capital-efficient market entry through organic licensing, and secures access to Texas’s ~30 million residents as patient access evolves.
Cresco Labs (OTCQX: CRLBF) reported Q4 2025 revenue of $162 million and fiscal 2025 revenue of $656 million, with strengthened margins and cash generation. Adjusted EBITDA was $40 million in Q4 and $157 million for the year. Operating cash flow was $27 million in Q4 and $73 million for the year.
The company posted a FY net loss of $140 million and Q4 net loss of $89 million reflecting one-time, non-cash impairment charges. Cash and equivalents totaled $91 million and senior secured term loan debt was $311 million.
Cresco Labs (OTCQX: CRLBF) will report full year and fourth quarter 2025 financial results on Thursday, March 5, 2026 before the market opens. A conference call and webcast are scheduled at 8:30 am ET to discuss results and business highlights.
Archived webcast access will be available for one year on the investor relations website. Dial-in and registration details are provided for investors.
Cresco Labs (OTCQX: CRLBF) entered an equity distribution agreement with Haywood Securities to establish an at-the-market (ATM) program to sell up to ~US$100 million (C$140 million) of subordinate voting shares.
Proceeds are intended for general corporate purposes, including potential acquisitions; no shares have been sold to date. The program is offered under a prospectus supplement dated January 29, 2026, and sales will occur on Canadian marketplaces in compliance with applicable securities laws.
Cresco Labs (OTCQX: CRLBF) opened Sunnyside Tamarac at 6001 N University Drive in Tamarac, Florida, marking its 31st dispensary in Florida and 72nd location nationwide.
The store offers products from Cresco Labs' brand portfolio including Cresco, FloraCal, Supply, Good News, Remedi and Sunnyside, plus accessories; orders can be placed in store or online at www.sunnyside.shop. Store hours: Monday–Friday 9:00 a.m.–8:00 p.m.; Sunday 9:00 a.m.–6:00 p.m.